Clinical Trials Logo
  1. Home
  2. Venous Leg Ulcer
  3. NCT01656889

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers

Venous Leg Ulcers Clinical Trial

Official title:
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers

Clinical Trial Summary

This study is being done to find out if an investigational product called HP802-247 can help people with venous leg ulcers. Investigational means that HP802-247 has not been approved by the U.S. Food and Drug Administration (FDA).

This research is being done to compare the efficacy of HP802-247 plus compression therapy against Vehicle plus compression therapy in achieving complete wound closure over the 12-week treatment period. Vehicle looks the same as HP802-247 but contains no cells.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01656889
Study type Interventional
Source Healthpoint
Contact
Status Completed
Phase Phase 3
Start date August 2012
Completion date December 2014
View Details
See also
  Status Clinical Trial Phase
Completed NCT00663091 - A Prospective, Randomized, Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg Ulcers Phase 1
Recruiting NCT02609594 - Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers N/A
Unknown status NCT02011724 - A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf® Phase 4
Active, not recruiting NCT01737762 - Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2 Phase 3
Completed NCT02222467 - Safety Evaluation of the KLOX BioPhotonic System in Venous Leg Ulcers N/A
Completed NCT01199588 - A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers Phase 2
Withdrawn NCT00953563 - The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers N/A
Enrolling by invitation NCT02047084 - Comparison of Human Allograft to Apligraf for Venous Leg Ulcers
Completed NCT02020746 - Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds Phase 2
Terminated NCT02154087 - A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers Phase 2
Completed NCT02470806 - Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT) N/A
Suspended NCT02577120 - Wound Healing Endpoint and Recurrence Phase 4
Completed NCT01743053 - A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers Phase 4
Recruiting NCT02312518 - A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Venous Leg Ulcers N/A
Recruiting NCT02352454 - Effectiveness of Aurix Therapy in Venous Leg Ulcers N/A
Withdrawn NCT02940587 - Effectiveness of Aurix Therapy in Venous Leg Ulcers Phase 4
Completed NCT01036438 - Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers Phase 4
Unknown status NCT02224300 - Nursing Care With Patients With Venous Leg Ulcers Phase 2
Completed NCT02422017 - Topical Timolol Benefit in Venous Ulcers Phase 2